Follow
John CHAPMAN
John CHAPMAN
Sorbonne University and Pitie-Salpetriere University Hospital
Verified email at upmc.fr
Title
Cited by
Cited by
Year
2016 ESC/EAS guidelines for the management of dyslipidaemias
AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ...
Polish Heart Journal (Kardiologia Polska) 74 (11), 1234-1318, 2016
8494*2016
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of …
F Mach, C Baigent, AL Catapano, KC Koskinas, M Casula, L Badimon, ...
European heart journal 41 (1), 111-188, 2020
79482020
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European …
BA Ference, HN Ginsberg, I Graham, KK Ray, CJ Packard, E Bruckert, ...
European heart journal 38 (32), 2459-2472, 2017
31802017
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of …
BG Nordestgaard, MJ Chapman, SE Humphries, HN Ginsberg, L Masana, ...
European heart journal 34 (45), 3478-3490, 2013
29832013
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray, J Borén, F Andreotti, GF Watts, ...
European heart journal 31 (23), 2844-2853, 2010
21172010
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
MJ Chapman, HN Ginsberg, P Amarenco, F Andreotti, J Borén, ...
European heart journal 32 (11), 1345-1361, 2011
15822011
Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society consensus panel statement on assessment, aetiology and management
ES Stroes, PD Thompson, A Corsini, GD Vladutiu, FJ Raal, KK Ray, ...
European heart journal 36 (17), 1012-1022, 2015
14842015
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European …
AL Catapano, Ž Reiner, G De Backer, I Graham, MR Taskinen, O Wiklund, ...
Atherosclerosis 217, 1-44, 2011
11662011
Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis
PJ Barter, HB Brewer Jr, MJ Chapman, CH Hennekens, DJ Rader, ...
Arteriosclerosis, thrombosis, and vascular biology 23 (2), 160-167, 2003
11062003
Effect of two intensive statin regimens on progression of coronary disease
SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ...
New England Journal of Medicine 365 (22), 2078-2087, 2011
10982011
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on …
M Cuchel, E Bruckert, HN Ginsberg, FJ Raal, RD Santos, RA Hegele, ...
European heart journal 35 (32), 2146-2157, 2014
10952014
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European …
J Boren, MJ Chapman, RM Krauss, CJ Packard, JF Bentzon, CJ Binder, ...
European heart journal 41 (24), 2313-2330, 2020
10322020
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
A Kontush, MJ Chapman
Pharmacological reviews 58 (3), 342-374, 2006
9782006
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia
JC Fruchart, F Sacks, MP Hermans, G Assmann, WV Brown, R Ceska, ...
The American journal of cardiology 102 (10), 1K-34K, 2008
924*2008
Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
A Wiegman, SS Gidding, GF Watts, MJ Chapman, HN Ginsberg, M Cuchel, ...
European heart journal 36 (36), 2425-2437, 2015
8932015
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets
G Barba, F Harper, T Harada, M Kohara, S Goulinet, Y Matsuura, G Eder, ...
Proceedings of the National Academy of Sciences 94 (4), 1200-1205, 1997
8471997
Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint …
BG Nordestgaard, A Langsted, S Mora, G Kolovou, H Baum, E Bruckert, ...
European heart journal 37 (25), 1944-1958, 2016
8292016
Animal lipoproteins: chemistry, structure, and comparative aspects.
MJ Chapman
7881981
Dysfunctional HDL and atherosclerotic cardiovascular disease
RS Rosenson, HB Brewer Jr, BJ Ansell, P Barter, MJ Chapman, ...
Nature reviews cardiology 13 (1), 48-60, 2016
7162016
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
BA Ference, JG Robinson, RD Brook, AL Catapano, MJ Chapman, ...
New England Journal of Medicine 375 (22), 2144-2153, 2016
7092016
The system can't perform the operation now. Try again later.
Articles 1–20